메뉴 건너뛰기




Volumn 29, Issue 2, 2012, Pages 222-223

Refractory symptoms successfully treated with leukotriene inhibition in a child with systemic mastocytosis

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CETIRIZINE; CROMOGLYCATE DISODIUM; MONTELUKAST; PREDNISOLONE; RANITIDINE; TRYPTASE;

EID: 84859109120     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2011.01576.x     Document Type: Article
Times cited : (27)

References (6)
  • 2
    • 77952111914 scopus 로고    scopus 로고
    • Increased leukotriene E4 excretion in systemic mastocytosis
    • Butterfield JH,. Increased leukotriene E4 excretion in systemic mastocytosis. Prostaglandins Other Lipid Mediat 2010; 92: 73-76.
    • (2010) Prostaglandins Other Lipid Mediat , vol.92 , pp. 73-76
    • Butterfield, J.H.1
  • 3
    • 0034795244 scopus 로고    scopus 로고
    • The cysteinyl leukotriene D4 receptor antagonist montelukast for the treatment of interstitial cystitis
    • Bouchelouche K, Nordling J, Hald T, et al., The cysteinyl leukotriene D4 receptor antagonist montelukast for the treatment of interstitial cystitis. J Urol 2001; 166: 1734-1737.
    • (2001) J Urol , vol.166 , pp. 1734-1737
    • Bouchelouche, K.1    Nordling, J.2    Hald, T.3
  • 4
    • 74849138144 scopus 로고    scopus 로고
    • Recent-onset bronchial asthma as a manifestation of systemic mastocytosis
    • Sancho-Chust JN, Chiner E, Camarasa A, et al., Recent-onset bronchial asthma as a manifestation of systemic mastocytosis. J Investig Allergol Clin Immunol 2009; 19: 513-515.
    • (2009) J Investig Allergol Clin Immunol , vol.19 , pp. 513-515
    • Sancho-Chust, J.N.1    Chiner, E.2    Camarasa, A.3
  • 5
    • 1442290031 scopus 로고    scopus 로고
    • Leukotriene-receptor inhibition for the treatment of systemic mastocytosis
    • Tolar J, Tope WD, Neglia JP,. Leukotriene-receptor inhibition for the treatment of systemic mastocytosis. N Engl J Med 2004; 350: 735-736.
    • (2004) N Engl J Med , vol.350 , pp. 735-736
    • Tolar, J.1    Tope, W.D.2    Neglia, J.P.3
  • 6
    • 66149119798 scopus 로고    scopus 로고
    • Cysteinyl leukotrienes enhance the degranulation of bone marrow-derived mast cells through the autocrine mechanism
    • Kaneko I, Suzuki K, Matsuo K, et al., Cysteinyl leukotrienes enhance the degranulation of bone marrow-derived mast cells through the autocrine mechanism. Tohoku J Exp Med 2009; 217: 185-191.
    • (2009) Tohoku J Exp Med , vol.217 , pp. 185-191
    • Kaneko, I.1    Suzuki, K.2    Matsuo, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.